Tagged with pharma

maintenance Mr. O’Neill, you have been managing director of this company for 17 years. How have you evolved the business over that period? ESS was founded in 1991, and I joined the business in 1996. The company’s initial vision was to provide flexibility to the maintenance market in Ireland and its…

Takeda Pharma GmbH Can you give our readers a snapshot of the scope of Takeda’s operations and the organizational structure within Austria? Takeda in Austria is a top-ten player with a turnover of roughly €80 million, according to IMS figures. In primary care markets we focus on core therapeutic areas such as cardiovascular…

Janssen Pharmaceutica Mr. Heyman, you inherited the chair and management of Janssen Pharmaceutica. What core values and spirit of Dr. Paul Janssen were you asked by the Janssen family to perpetuate throughout the years? Tom Heyman: Janssen Pharmaceutica is all about innovation—developing, producing and providing innovative healthcare solutions for patients. When I…

Pharmachemical Ireland Mr. Moran, can you please begin with a brief introduction to Pharmachemical Ireland, its mission, and how it works to achieve its goals?   Pharmachemical Ireland (PCI) is an industry association representing the pharmaceutical, chemical, and biopharmaceutical manufacturing sectors in Ireland. Our raison d’être is to ensure that the regulatory…

Leo Pharma Ireland This interview also features the comments of Geraldine Murphy, Managing Director of Leo Pharma, Ireland. Ms. Murphy, your transition to your current position was precipitated by a major refocusing that LEO Pharma undertook in the first half of this year. Can you tell us your understanding of the vision behind…

Leo Pharma Ireland This interview also features the comments of Brendan Fitzpatrick, Vice President Finished Goods Manufacturing. Ms. Murphy, your transition to your current position was precipitated by a major refocusing that LEO Pharma undertook in the first half of this year. Can you tell us your understanding of the vision behind the…

Meda Pharma Austria What have been the most significant developments as a result of the acquisition of Viatris by Meda Pharma in 2005? At that time Viatris was a small company, and there was a distinct lack of enthusiasm and forward thinking strategy. Because the financial investors running Viatris wanted to sell the…

Savira pharmaceuticals You previously worked as CSO for onepharm; what was the motivation for creating Savira? OS: When I was working at onepharm, the organization was focused on anti-influenza and anti-inflammatory drug development. In late 2008, the enterprise management organization of the European Molecular Biology Laboratory (EMBL) was seeking for an industrial…

Irish Pharmaceutical Healthcare Association With an evident recession and cost-cutting measures abound Ms. Nolan elaborates on the new plain on which pharmaceutical players have found themselves upon and how they have adjusted to the recent climate in Ireland. Miss Nolan, you have been chief executive of the IPHA since 1994. How have you seen…

CECyC Pharma Mexico With the new drug registration laws that were announced in 2005, was CECyC Pharma initiated as result of this new law, or pre-emptively because you saw that the market was due to change? We started operations in 2005 as an authorized third party bioequivalence and clinical trials center. Companies like…

Leo Pharma Austria You have been managing LEO Pharma’s Austrian operations since March 2012. How do you look back at these first few months? And what have been your first initiatives at the head of the affiliate? 2012 has overall been an interesting year, as LEO Pharma stepped into new fields of indication…

ASLAN pharmaceuticals Why did you decide to start your own company? I started my career as a scientist with a real passion for molecular biology, and moved into pharmaceutical R&D working for AstraZeneca. After five or so years I was very keen to get commercial exposure, to see how we actually access…